Enveric Biosciences Inc (ENVB NASDAQ) stock market data APIs
$0.9162
0.03(3.3%)
as of September 16, 2025
Try our APIs with
free plan!
Enveric Biosciences Inc Financial Data Overview
Price chart is built with
Anychart
Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. The company offers product candidates are EB-002, an active metabolite of psilocybin, which is in preclinical development stage for the treatment of anxiety disorders; and EB-003 that is in preclinical development stage for the treatment mental health. It also focuses on the development of cannabinoid conjugate molecules for the treatment of pain and cancer. The company is headquartered in Cambridge, Massachusetts.
Prev. Close
0.9162
Open
0.9487
High
1.0351
Low
0.8564
52 wk Range
0.85-8.325
Market Cap
2 970 K
Shares Outstanding
3 246 K
Revenue
35 405 K
EPS
-0.97
Beta
0.369
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Enveric Biosciences Inc data using free add-ons & libraries
Get Enveric Biosciences Inc Fundamental Data
Enveric Biosciences Inc Fundamental data includes:
- Net Revenue: 35 405 K
- EBITDA: -9 675 295
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-14
- EPS/Forecast: -0.35
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Enveric Biosciences Inc News
New
Enveric Biosciences Gets FDA Response On Request For Pre-IND Type B Meeting For Lead Program EB-003
(RTTNews) - Biotechnology company Enveric Biosciences, Inc. (ENVB) announced Tuesday that it has received a written response from the U.S. Food and Drug Administration (FDA) to its request for a Pre-I...
Enveric Biosciences receives second patent allowance for PTSD drug
CAMBRIDGE, Mass. - Enveric Biosciences (NASDAQ:ENVB) announced Wednesday it has received a second Notice of Allowance from the United States Patent and Trademark Office for compounds in its EVM401 Ser...
Enveric's lead drug candidate shows additional receptor activity
CAMBRIDGE, Mass. - Enveric Biosciences (NASDAQ:ENVB), a biotechnology company currently trading at $1.25 per share and showing signs of being undervalued according to InvestingPro Fair Value metrics, ...
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Key Takeaways; Cannabis Sector Scotts Miracle-Gro will finally separate its cannabis arm, Hawthorne, into a stand-alone cannabis business High Tide narrowed losses in 2024 amid record revenue and exp...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
